Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial

Naslov

Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial

Identifikator

/unibl/sci/idNaucniRad:24617

Tip

Datum

Bibliografski citat

W. Park, LJ. Božić, D. Milakovic, A. Berrocal Kasay, E. El-Khouri, F. Irazoque-Palazuelos, F. Molina, P. Shesternya, P. Miranda, F. Medina-Rodriguez, Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial, STED Journal, pp. 934 - 943, Aug, 2018

Početna stranica

934

Krajnja stranica

943

Je dio

STED Journal
2637-2150

Lista autora

Position: 1212 (53 views)